Engineering - Industrial Equipments · Founded 1976 · www.inoxcva.com · BSE 544046 · NSE INOXINDIA · ISIN INE616N01034
No Notes Added Yet
Business
Inox India Ltd. is a leading manufacturer of cryogenic equipment and solutions. The company specializes in designing, engineering, manufacturing, and installing a wide range of standard and engineered cryogenic tanks, equipment, and systems. Its core business revolves around providing solutions for the storage, transportation, and delivery of cryogenic gases (gases stored at very low temperatures), including industrial gases (liquid nitrogen, oxygen, argon, carbon dioxide), liquefied natural gas (LNG), and other specialized gases like helium and hydrogen. Inox India makes money by selling these specialized equipment and integrated solutions to various end-user industries globally, including industrial gas companies, oil & gas, healthcare, chemicals, food processing, and space research.
Revenue Mix
While specific percentage breakdowns can vary, Inox India's business can generally be segmented by the type of cryogenic solution or application:
Industrial Gas: Manufacturing and supply of cryogenic storage tanks, vaporizers, and systems for industrial gases like LIN, LOX, LAR, CO2, N2O, and Helium. This forms a significant portion due to widespread industrial applications.
LNG: Solutions for the entire LNG value chain, including LNG storage tanks, transport tankers (like LCNG cascades), and regasification solutions. This segment is growing rapidly with increasing LNG adoption.
Cryo Scientific & Others: Includes specialized cryogenic equipment for research & development, space exploration, healthcare (e.g., medical oxygen tanks, MRI cooling), and specific industrial processes. The company also offers after-sales services and spare parts.
Industry
Inox India operates in the specialized global cryogenic equipment industry, which is characterized by high technical complexity, stringent safety standards, and capital intensiveness. The industry is driven by the demand for industrial gases, cleaner energy (LNG), healthcare infrastructure, and advancements in scientific research. In India, Inox India is a market leader and one of the largest manufacturers of cryogenic storage and transport tanks. Globally, it competes with specialized international players. Its strong domestic presence, coupled with a growing export footprint (serving over 100 countries), positions it as a significant player with established credibility and technical capabilities, especially in emerging markets.
MOAT
Technological Expertise & R&D: Cryogenic engineering is complex, requiring specialized know-how in materials, welding, insulation, and safety protocols. Inox India has a long track record and significant investments in R&D, leading to robust product designs and custom solutions.
High Switching Costs: For critical industrial infrastructure like cryogenic storage and transport, replacing an installed system or switching suppliers involves significant cost, operational disruption, and re-certification processes, creating stickiness for existing customers.
Strong Brand & Track Record: Decades of operational experience and a proven track record of delivering reliable and safe solutions for critical applications have built a strong brand reputation, crucial for gaining customer trust in a high-stakes industry.
Quality & Safety Certifications: Compliance with international safety and quality standards (e.g., ASME, PED, CE, EN) is a key barrier to entry and a competitive differentiator.
Integrated Capabilities: Ability to offer end-to-end solutions from design to manufacturing, installation, and after-sales service provides a comprehensive offering to clients.
Growth Drivers
Energy Transition & LNG Adoption: Expanding global infrastructure for LNG (including small-scale LNG, LCNG stations, and bunkering) as a cleaner fuel source is a major driver.
Industrialization & Economic Growth: Growing demand for industrial gases (oxygen, nitrogen, argon) across manufacturing, steel, chemicals, and electronics sectors, particularly in developing economies.
Healthcare Infrastructure Expansion: Increasing demand for medical oxygen and other cryogenic gases for healthcare facilities, especially post-pandemic.
Emerging Applications: Potential growth from new applications like the hydrogen economy (storage and transport of liquid hydrogen) and specialized aerospace and defense projects.
Export Market Expansion: Continued focus on expanding geographical reach in diverse international markets, leveraging its cost-effective manufacturing and technical capabilities.
Risks
Project-based Cyclicality: Demand for large cryogenic equipment can be lumpy and dependent on capital expenditure cycles of industrial gas companies and energy projects. Delays or cancellations of large projects can impact revenue and profitability.
Raw Material Price Volatility: Fluctuations in prices of key raw materials like stainless steel, which is a major input, can impact manufacturing costs and margins if not effectively hedged or passed on to customers.
Intense Competition: Competition from domestic players and larger international cryogenic equipment manufacturers, particularly in global markets, can exert pressure on pricing and market share.
Technological Obsolescence: While cryogenic technology is mature, rapid advancements in alternative energy storage or gas separation technologies could pose a long-term risk.
Regulatory & Safety Standards: Non-compliance or changes in stringent safety and environmental regulations for handling hazardous cryogenic materials could lead to operational hurdles or increased costs.
Management & Ownership
Inox India Ltd. is a promoter-led company, part of the Inox GFL Group, a diversified Indian conglomerate with interests in chemicals, refrigeration, and renewable energy. The promoter group, with a significant ownership stake, has a long history in industrial gases and related equipment manufacturing. The management team typically comprises experienced professionals with deep domain knowledge in engineering and industrial equipment. This promoter-led structure often implies a long-term strategic vision and commitment to the business.
Outlook
Inox India is well-positioned to capitalize on the growing global demand for cryogenic solutions, driven by the energy transition (especially LNG), continued industrialization, and expanding healthcare needs. Its strong market leadership in India, established technological expertise, and expanding global footprint provide a solid foundation for growth. However, the company operates in a capital-intensive and project-driven industry, which inherently carries risks of cyclicality, raw material price fluctuations, and intense competition. The ability to efficiently execute large and complex projects, manage supply chain disruptions, and adapt to evolving energy landscapes will be crucial for sustaining its growth trajectory and profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 291 | 277 | 296 | 307 | 334 | 369 | 340 | 358 | 429 | 461 |
| Other Income | 5 | 11 | 5 | 13 | 9 | 13 | 13 | 11 | 7 | 15 |
| Total Income | 295 | 288 | 302 | 320 | 342 | 383 | 352 | 369 | 436 | 475 |
| Total Expenditure | 224 | 223 | 226 | 243 | 265 | 288 | 263 | 280 | 334 | 366 |
| Operating Profit | 71 | 64 | 76 | 77 | 78 | 95 | 89 | 89 | 101 | 109 |
| Interest | 2 | 2 | 2 | 3 | 3 | 1 | 1 | 2 | 3 | 4 |
| Depreciation | 5 | 5 | 6 | 6 | 6 | 7 | 8 | 8 | 9 | 9 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 2 | -8 | 3 |
| Profit Before Tax | 64 | 58 | 68 | 69 | 76 | 86 | 81 | 81 | 80 | 100 |
| Provision for Tax | 15 | 14 | 15 | 19 | 18 | 21 | 19 | 20 | 20 | 25 |
| Profit After Tax | 49 | 44 | 53 | 49 | 58 | 66 | 61 | 61 | 61 | 75 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 49 | 44 | 53 | 49 | 58 | 66 | 61 | 61 | 61 | 75 |
| Adjusted Earnings Per Share | 5.4 | 4.9 | 5.8 | 5.5 | 6.4 | 7.2 | 6.7 | 6.7 | 6.7 | 8.3 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 460 | 433 | 559 | 643 | 649 | 595 | 783 | 966 | 1133 | 1306 | 1587 | 1588 |
| Other Income | 5 | 16 | 13 | 10 | 43 | 22 | 21 | 20 | 31 | 41 | 47 | 46 |
| Total Income | 465 | 449 | 572 | 654 | 692 | 617 | 804 | 986 | 1165 | 1347 | 1634 | 1632 |
| Total Expenditure | 478 | 422 | 523 | 500 | 516 | 466 | 615 | 762 | 883 | 1021 | 1246 | 1243 |
| Operating Profit | -13 | 27 | 49 | 154 | 176 | 151 | 189 | 225 | 282 | 325 | 388 | 388 |
| Interest | 35 | 41 | 28 | 27 | 25 | 7 | 2 | 4 | 6 | 9 | 9 | 10 |
| Depreciation | 32 | 23 | 9 | 9 | 12 | 12 | 12 | 14 | 18 | 25 | 34 | 34 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | -3 | -3 |
| Profit Before Tax | -79 | -38 | 11 | 117 | 138 | 133 | 174 | 207 | 258 | 299 | 342 | 342 |
| Provision for Tax | 7 | -0 | 10 | -59 | 46 | 35 | 44 | 52 | 62 | 73 | 84 | 84 |
| Profit After Tax | -86 | -38 | 1 | 176 | 92 | 97 | 130 | 155 | 196 | 226 | 258 | 258 |
| Adjustments | 22 | 0 | 0 | 17 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -65 | -38 | 1 | 193 | 98 | 98 | 130 | 155 | 196 | 226 | 258 | 258 |
| Adjusted Earnings Per Share | -7.1 | -4.1 | 0.1 | 21.2 | 10.8 | 10.8 | 14.4 | 17 | 21.6 | 24.9 | 28.4 | 28.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 22% | 18% | 22% | 13% |
| Operating Profit CAGR | 19% | 20% | 21% | 0% |
| PAT CAGR | 14% | 19% | 22% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 23% | NA% | NA% | NA% |
| ROE Average | 26% | 30% | 30% | 15% |
| ROCE Average | 34% | 39% | 38% | 27% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 70 | 19 | 19 | 210 | 279 | 372 | 502 | 549 | 649 | 874 | 1118 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 202 | 213 | 88 | 59 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1 | 4 | 14 | -43 | 15 | 21 | 22 | 28 | 31 | 21 | 19 |
| Total Current Liabilities | 530 | 587 | 400 | 443 | 326 | 294 | 373 | 570 | 543 | 759 | 875 |
| Total Liabilities | 804 | 824 | 768 | 674 | 627 | 687 | 897 | 1148 | 1223 | 1654 | 2012 |
| Fixed Assets | 296 | 276 | 96 | 94 | 110 | 102 | 134 | 164 | 255 | 359 | 428 |
| Other Non-Current Assets | 103 | 8 | 80 | 84 | 3 | 56 | 10 | 10 | 21 | 20 | 17 |
| Total Current Assets | 406 | 539 | 367 | 480 | 505 | 521 | 743 | 962 | 936 | 1265 | 1555 |
| Total Assets | 804 | 824 | 768 | 674 | 627 | 687 | 897 | 1148 | 1223 | 1654 | 2012 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 17 | 10 | 3 | 3 | 37 | 30 | 2 | 1 | 11 | 5 | 4 |
| Cash Flow from Operating Activities | 93 | 54 | 83 | 85 | 188 | 231 | 97 | 177 | 122 | 122 | 117 |
| Cash Flow from Investing Activities | -23 | 5 | 88 | 143 | -5 | -159 | -75 | -12 | -25 | -139 | -110 |
| Cash Flow from Financing Activities | -64 | -55 | -169 | -186 | -168 | -96 | -26 | -154 | -103 | 17 | 5 |
| Net Cash Inflow / Outflow | 6 | 4 | 2 | 42 | 15 | -24 | -4 | 11 | -6 | -0 | 12 |
| Closing Cash & Cash Equivalent | 10 | 3 | 2 | 42 | 30 | 2 | 1 | 11 | 5 | 4 | 16 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -7.11 | -4.14 | 0.15 | 21.25 | 10.82 | 10.81 | 14.38 | 17.05 | 21.59 | 24.9 | 28.41 |
| CEPS(Rs) | -6.03 | -1.56 | 1.18 | 20.41 | 11.45 | 12.04 | 15.71 | 18.58 | 23.59 | 27.66 | 32.12 |
| DPS(Rs) | 0.1 | 0 | 0 | 0.1 | 0.2 | 0 | 1.5 | 11 | 11 | 2 | 2 |
| Book NAV/Share(Rs) | 7.73 | 2.11 | 2.14 | 23.09 | 30.79 | 40.99 | 55.34 | 60.54 | 70.92 | 95.6 | 122.05 |
| Core EBITDA Margin(%) | -3.78 | 2.43 | 6.47 | 22.3 | 20.46 | 21.67 | 21.42 | 21.16 | 22.08 | 21.8 | 21.46 |
| EBIT Margin(%) | -9.52 | 0.76 | 7.04 | 22.45 | 25.24 | 23.47 | 22.55 | 21.81 | 23.25 | 23.54 | 22.13 |
| Pre Tax Margin(%) | -16.86 | -8.46 | 2.01 | 18.19 | 21.31 | 22.31 | 22.26 | 21.42 | 22.74 | 22.89 | 21.54 |
| PAT Margin (%) | -18.36 | -8.45 | 0.24 | 27.33 | 14.17 | 16.39 | 16.67 | 16.02 | 17.29 | 17.31 | 16.25 |
| Cash Profit Margin (%) | -11.63 | -3.2 | 1.91 | 28.79 | 16.01 | 18.37 | 18.22 | 17.46 | 18.89 | 19.23 | 18.37 |
| ROA(%) | -10.75 | -4.61 | 0.17 | 24.39 | 14.14 | 14.84 | 16.48 | 15.14 | 16.53 | 15.71 | 14.07 |
| ROE(%) | -123.27 | -84.03 | 6.95 | 153.59 | 37.61 | 29.93 | 29.85 | 29.42 | 32.85 | 29.91 | 26.11 |
| ROCE(%) | -7.51 | 0.58 | 9.33 | 37.28 | 35.68 | 32.58 | 36.1 | 38.46 | 43.78 | 39.4 | 33.54 |
| Receivable days | 37.51 | 54.48 | 67.7 | 77.28 | 83 | 79.68 | 44.5 | 41.76 | 51.01 | 59.46 | 64.91 |
| Inventory Days | 227.56 | 240.1 | 152.07 | 113.21 | 107.66 | 94.21 | 109.2 | 138.93 | 136.33 | 129.52 | 111.68 |
| Payable days | 86.38 | 103.54 | 84.63 | 38.92 | 25.6 | 24.51 | 31.06 | 42.84 | 67.28 | 82.94 | 75.87 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 56.5 | 40.14 | 41.27 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.2 | 10.46 | 9.61 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.9 | 0.2 | 0.17 |
| EV/Net Sales(x) | 1.12 | 1.27 | 0.44 | 0.35 | 0.15 | -0.22 | 0.07 | -0.05 | 9.77 | 6.96 | 6.74 |
| EV/Core EBITDA(x) | -39.11 | 20.59 | 5.08 | 1.48 | 0.54 | -0.87 | 0.28 | -0.19 | 39.31 | 27.92 | 27.55 |
| Net Sales Growth(%) | 0 | -5.92 | 29.27 | 15.02 | 0.87 | -8.37 | 31.61 | 23.4 | 17.34 | 15.23 | 21.52 |
| EBIT Growth(%) | 0 | 107.5 | 1075.92 | 265.49 | 13.4 | -14.81 | 26.48 | 19.31 | 25.08 | 16.71 | 14.2 |
| PAT Growth(%) | 0 | 56.59 | 103.58 | 0 | -47.71 | 6 | 33.87 | 18.58 | 26.67 | 15.32 | 14.1 |
| EPS Growth(%) | 0 | 41.88 | 103.58 | 0 | -49.05 | -0.17 | 33.06 | 18.57 | 26.67 | 15.32 | 14.1 |
| Debt/Equity(x) | 7.48 | 28.49 | 13.48 | 1.36 | 0.52 | 0.16 | 0.09 | 0 | 0.01 | 0.04 | 0.06 |
| Current Ratio(x) | 0.77 | 0.92 | 0.92 | 1.08 | 1.55 | 1.77 | 1.99 | 1.69 | 1.72 | 1.67 | 1.78 |
| Quick Ratio(x) | 0.21 | 0.42 | 0.47 | 0.58 | 1.05 | 1.27 | 1.13 | 0.96 | 0.93 | 1.02 | 1.23 |
| Interest Cover(x) | -1.3 | 0.08 | 1.4 | 5.27 | 6.43 | 20.35 | 75.96 | 57.16 | 46.46 | 35.98 | 38.04 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 4.65 | 6.14 | 6.38 | 5.84 | 6.52 | 6.84 | 6.94 | 7.12 | 7.14 | 7.13 |
| DII | 6.48 | 6.59 | 6.73 | 7.14 | 6.99 | 6.25 | 6.68 | 6.71 | 7.27 | 7.72 |
| Public | 13.87 | 12.27 | 11.89 | 12.03 | 11.49 | 11.9 | 11.38 | 11.17 | 10.59 | 10.15 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 |
| FII | 0.42 | 0.56 | 0.58 | 0.53 | 0.59 | 0.62 | 0.63 | 0.65 | 0.65 | 0.65 |
| DII | 0.59 | 0.6 | 0.61 | 0.65 | 0.63 | 0.57 | 0.61 | 0.61 | 0.66 | 0.7 |
| Public | 1.26 | 1.11 | 1.08 | 1.09 | 1.04 | 1.08 | 1.03 | 1.01 | 0.96 | 0.92 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +22% | +18% | +22% | +13% |
| Operating Profit CAGR | +19% | +20% | +21% | — |
| PAT CAGR | +14% | +19% | +22% | — |
| Share Price CAGR | +23% | — | — | — |
| ROE Average | +26% | +30% | +30% | +15% |
| ROCE Average | +34% | +39% | +38% | +27% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 4.65 | 6.14 | 6.38 | 5.84 | 6.52 | 6.84 | 6.94 | 7.12 | 7.14 | 7.13 |
| DII | 6.48 | 6.59 | 6.73 | 7.14 | 6.99 | 6.25 | 6.68 | 6.71 | 7.27 | 7.72 |
| Public | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 |
| FII | 0.42 | 0.56 | 0.58 | 0.53 | 0.59 | 0.62 | 0.63 | 0.65 | 0.65 | 0.65 |
| DII | 0.59 | 0.6 | 0.61 | 0.65 | 0.63 | 0.57 | 0.61 | 0.61 | 0.66 | 0.7 |
| Public | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.